Enopace Biomedical

EnoPace is a clinical-stage medical device company focused on developing the Harmony System, a minimally invasive neurostimulator aimed at improving heart function and alleviating the burden of congestive heart failure (CHF). Their innovative technology utilizes catheter-based delivery to stimulate heart tissue, enhancing left ventricle function an... d overall cardiac output. The company targets interventional cardiologists, health systems, institutional investors, and research institutions, providing a clinically validated platform recognized for its advancements in cardiovascular therapy. With operations in North America and Israel, EnoPace is committed to addressing one of the largest unmet needs in modern medicine.Read More